Allergies News and Research

Latest Allergies News and Research

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Reversing history, Indian Health Service seeks traditional healers

Cheryl Morales started the medicinal garden at the Aaniiih Nakoda College demonstration farm with only four plants: yarrow, echinacea, plantain and licorice root.

14 May 2020

Cats can readily become infected with SARS-CoV-2, confirms study

In a study published today (May 13, 2020) in the New England Journal of Medicine, scientists in the U.S. and Japan report that in the laboratory, cats can readily become infected with SARS-CoV-2, the virus that causes COVID-19, and may be able to pass the virus to other cats.

14 May 2020

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

The country's first convalescent plasma transfusion trial results have been published and show 19 out of 25 patients improved with the treatment, and 11 were discharged from the hospital.

13 May 2020

Study finds potential under-diagnosis of food allergy among Medicaid-enrolled children

Prevalence of food allergy among Medicaid-enrolled children across the U.S. was substantially lower (0.6 percent), compared to previous national estimates using parent surveys (7.6 percent) and reports of physician confirmation of food allergy (4.7 percent).

13 May 2020

Vaccine design can face specific challenges, say researchers

The goal of a vaccine is to trigger a response that safely protects against an infection and/or the burden of disease.

13 May 2020

Too little sleep can negatively impact adults with asthma

A good night's sleep is crucial to good health. A new article in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology reveals that too little sleep, and occasionally too much sleep, can negatively impact adults with asthma.

12 May 2020

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science.

12 May 2020

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Over the past few months, doctors resorted to repurposing medicines that have already been approved for other diseases to treat coronavirus patients. One drug that was widely used in the pandemic, hydroxychloroquine, has been found to be ineffective in treating the viral infection.

11 May 2020

New diagnostic approach has potential to enhance infectious diseases surveillance

A new technique could provide vital information about a community's immunity to infectious diseases including malaria and COVID-19.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Common allergy medicine may improve survival in patients with malignant melanoma

Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.

11 May 2020

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Allergies can significantly affect health and quality of life. While allergen immunotherapy provides long-lasting therapeutic relief to people suffering from environmental allergies, the therapy can last several years and requires large amounts of allergen.

11 May 2020

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

As the world grapples with the coronavirus disease (COVID-19), scientists race to develop treatments and vaccines to combat the viral infection. Though many ongoing trials show promise in fighting the novel coronavirus, Italian researchers claim they have developed a vaccine that can neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal cells.

10 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020

Study shows how air pollution makes COVID-19 mortality worse for marginalized populations

As scientists worldwide race to gather data about the novel coronavirus, one of the more surprising findings has been detecting the virus attached to fine particles of air pollution.

8 May 2020

The nutritional key to control autoimmunity and cancer

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

8 May 2020

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

8 May 2020

Allergies News and Research

Latest Allergies News and Research

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

Reversing history, Indian Health Service seeks traditional healers

Cats can readily become infected with SARS-CoV-2, confirms study

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Study finds potential under-diagnosis of food allergy among Medicaid-enrolled children

Vaccine design can face specific challenges, say researchers

Too little sleep can negatively impact adults with asthma

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

New diagnostic approach has potential to enhance infectious diseases surveillance

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Common allergy medicine may improve survival in patients with malignant melanoma

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

Study shows how air pollution makes COVID-19 mortality worse for marginalized populations

The nutritional key to control autoimmunity and cancer

Most COVID-19 patients lose sense of smell by the third day, shows study

Predicting How Contact Tracing Can Control the Spread of COVID-19

Measuring the binding of SARS-CoV-2 Antibodies to the COVID Spike Protein using SPR

Identifying the Starting Points for COVID-19 Treatment

Allergies News and Research

Latest Allergies News and Research

Newsletters you may be interested in